Zheng, Zhili

Cancer regression in patients after transfer of genetically engineered lymphocytes

Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 2,603

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

Tran, E., Robbins, P. F., Lu, Y.-C., Prickett, T. D., Gartner, J. J., Jia, L., Pasetto, A., Zheng, Z., Ray, S., Groh, E. M., et al. (2016) · New England Journal of Medicine

Immunotherapy and Immune ResponsesCAR-T cell therapy research

Cited by 1,368

Immunogenicity of somatic mutations in human gastrointestinal cancers

Tran, E., Ahmadzadeh, M., Lu, Y.-C., Gros, A., Turcotte, S., Robbins, P. F., Gartner, J. J., Zheng, Z., Li, Y. F., Ray, S., et al. (2015) · Science

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 729

High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation

Zhao, Y., Zheng, Z., Cohen, C. J., Gattinoni, L., Palmer, D. C., Restifo, N. P., Rosenberg, S. A., & Morgan, R. A. (2006) · Molecular Therapy

Microbial Inactivation MethodsRNA Interference and Gene Delivery

Cited by 283

Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain

Mikkilineni, L., Natrakul, D. A., Lam, N., Manasanch, E. E., Mann, J., Weissler, K. A., Wong, N., Brudno, J. N., Goff, S. L., Yang, J. C., et al. (2024) · Molecular Therapy

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 16

Oxidative damage by phenylhydrazine diminishes erythrocyte anion transport

Petty, H. R., Zhou, M.-J., & Zheng, Z. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes

Erythrocyte Function and PathophysiologyRedox biology and oxidative stress

Cited by 9